476 related articles for article (PubMed ID: 17662091)
21. Beyond TPMT: genetic influences on thiopurine drug responses in inflammatory bowel disease.
Roberts RL; Gearry RB; Kennedy MA; Barclay ML
Per Med; 2008 May; 5(3):233-248. PubMed ID: 29783500
[TBL] [Abstract][Full Text] [Related]
22. Does lymphopenia or macrocytosis reflect 6-thioguanine levels in patients with inflammatory bowel disease treated with azathioprine or 6-mercaptopurine?
Heerasing NM; Ng JF; Dowling D
Intern Med J; 2016 Apr; 46(4):465-9. PubMed ID: 26425841
[TBL] [Abstract][Full Text] [Related]
23. [Optimising azathioprine treatment: determination of thiopurine methyltransferase activity and thiopurine metabolites].
Alvarez Beltran M; Infante Pina D; Tormo Carnicé R; Segarra Cantón O; Redecillas Ferreiro S
An Pediatr (Barc); 2009 Feb; 70(2):126-31. PubMed ID: 19217567
[TBL] [Abstract][Full Text] [Related]
24. HPLC/tandem ion trap mass detector methods for determination of inosine monophosphate dehydrogenase (IMPDH) and thiopurine methyltransferase (TPMT).
Kalsi K; Marinaki AM; Yacoub MH; Smolenski RT
Nucleosides Nucleotides Nucleic Acids; 2006; 25(9-11):1241-4. PubMed ID: 17065099
[TBL] [Abstract][Full Text] [Related]
25. Thiopurine methyltransferase activity and its relationship to the occurrence of rejection episodes in paediatric renal transplant recipients treated with azathioprine.
Dervieux T; Médard Y; Baudouin V; Maisin A; Zhang D; Broly F; Loirat C; Jacqz-Aigrain E
Br J Clin Pharmacol; 1999 Dec; 48(6):793-800. PubMed ID: 10594482
[TBL] [Abstract][Full Text] [Related]
26. Comparison of three methods for measuring thiopurine methyltransferase activity in red blood cells and human leukemia cells.
Karim H; Appell ML; Fotoohi A
J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Nov; 939():80-5. PubMed ID: 24113235
[TBL] [Abstract][Full Text] [Related]
27. Thiopurine Methyltransferase Genetic Polymorphisms and Activity and Metabolic Products of Azathioprine in Patients with Inflammatory Bowel Disease.
Pashazadeh P; Marjani A; Asadi J; Khoshnia M
Endocr Metab Immune Disord Drug Targets; 2019; 19(4):541-547. PubMed ID: 30451123
[TBL] [Abstract][Full Text] [Related]
28. Monitoring of thiopurine metabolites in patients with inflammatory bowel disease-what is actually measured?
Vikingsson S; Carlsson B; Almer SH; Peterson C
Ther Drug Monit; 2009 Jun; 31(3):345-50. PubMed ID: 19363461
[TBL] [Abstract][Full Text] [Related]
29. Monitoring of thiopurine methyltransferase activity in postsurgical patients with Crohn's disease during 1 year of treatment with azathioprine or mesalazine.
Dilger K; Schaeffeler E; Lukas M; Strauch U; Herfarth H; Müller R; Schwab M
Ther Drug Monit; 2007 Feb; 29(1):1-5. PubMed ID: 17304143
[TBL] [Abstract][Full Text] [Related]
30. Thiopurine pharmacogenetics in leukemia: correlation of erythrocyte thiopurine methyltransferase activity and 6-thioguanine nucleotide concentrations.
Lennard L; Van Loon JA; Lilleyman JS; Weinshilboum RM
Clin Pharmacol Ther; 1987 Jan; 41(1):18-25. PubMed ID: 3467886
[TBL] [Abstract][Full Text] [Related]
31. A 6-thioguanine nucleotide threshold level of 400 pmol/8 x 10(8) erythrocytes predicts azathioprine refractoriness in patients with inflammatory bowel disease and normal TPMT activity.
Roblin X; Peyrin-Biroulet L; Phelip JM; Nancey S; Flourie B
Am J Gastroenterol; 2008 Dec; 103(12):3115-22. PubMed ID: 19086961
[TBL] [Abstract][Full Text] [Related]
32. Thiopurine methyltransferase gene polymorphisms and activity in Chinese patients with inflammatory bowel disease treated with azathioprine.
Zhu Q; Cao Q
Chin Med J (Engl); 2012 Oct; 125(20):3665-70. PubMed ID: 23075721
[TBL] [Abstract][Full Text] [Related]
33. Monitoring of long-term thiopurine therapy among adults with inflammatory bowel disease.
Hindorf U; Lyrenäs E; Nilsson A; Schmiegelow K
Scand J Gastroenterol; 2004 Nov; 39(11):1105-12. PubMed ID: 15545169
[TBL] [Abstract][Full Text] [Related]
34. Use of thiopurine testing in the management of inflammatory bowel diseases in clinical practice: a worldwide survey of experts.
Roblin X; Oussalah A; Chevaux JB; Sparrow M; Peyrin-Biroulet L
Inflamm Bowel Dis; 2011 Dec; 17(12):2480-7. PubMed ID: 21351210
[TBL] [Abstract][Full Text] [Related]
35. Relationship Between Thiopurine S-Methyltransferase Genotype/Phenotype and 6-Thioguanine Nucleotide Levels in 316 Patients With Inflammatory Bowel Disease on 6-Thioguanine.
Bayoumy AB; Mulder CJJ; Loganayagam A; Sanderson JD; Anderson S; Boekema PJ; Derijks LJJ; Ansari AR
Ther Drug Monit; 2021 Oct; 43(5):617-623. PubMed ID: 34521801
[TBL] [Abstract][Full Text] [Related]
36. Thiopurine S-methyltransferase genotype and the use of thiopurines in paediatric inflammatory bowel disease Greek patients.
Gazouli M; Pachoula I; Panayotou I; Mantzaris G; Syriopoulou VP; Goutas N; Vlachodimitropoulos D; Anagnou NP; Roma-Giannikou E
J Clin Pharm Ther; 2010 Feb; 35(1):93-7. PubMed ID: 20175817
[TBL] [Abstract][Full Text] [Related]
37. ITPA Activity in Adults and Children Treated With or Without Azathioprine: Relationship Between TPMT Activity, Thiopurine Metabolites, and Co-medications.
Citterio-Quentin A; Moulsma M; Gustin MP; Boulieu R
Ther Drug Monit; 2017 Oct; 39(5):483-491. PubMed ID: 28650902
[TBL] [Abstract][Full Text] [Related]
38. Prospective study of the effects of concomitant medications on thiopurine metabolism in inflammatory bowel disease.
Daperno M; Sostegni R; Canaparo R; Serpe L; Lavagna A; Crocellà L; Castagno F; Vernetto A; Rigazio C; Ercole E; D'Antico S; Pera A; Zara G; Rocca R
Aliment Pharmacol Ther; 2009 Oct; 30(8):843-53. PubMed ID: 19650826
[TBL] [Abstract][Full Text] [Related]
39. Deletion of glutathione-s-transferase m1 reduces azathioprine metabolite concentrations in young patients with inflammatory bowel disease.
Stocco G; Cuzzoni E; De Iudicibus S; Franca R; Favretto D; Malusà N; Londero M; Cont G; Bartoli F; Martelossi S; Ventura A; Decorti G
J Clin Gastroenterol; 2014 Jan; 48(1):43-51. PubMed ID: 23787247
[TBL] [Abstract][Full Text] [Related]
40. High TPMT enzyme activity does not explain drug resistance due to preferential 6-methylmercaptopurine production in patients on thiopurine treatment.
van Egmond R; Chin P; Zhang M; Sies CW; Barclay ML
Aliment Pharmacol Ther; 2012 May; 35(10):1181-9. PubMed ID: 22486532
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
